These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6681033)
1. Effects of bromocriptine on the circadian rhythm of 18-hydroxycorticosterone and cortisol secretion in essential hypertensives. Sowers JR; Tuck ML; Beck FW; Stern N J Hypertens; 1983 Aug; 1(2):141-4. PubMed ID: 6681033 [TBL] [Abstract][Full Text] [Related]
2. Influence of sodium homeostasis and circadian rhythm on dopaminergic modulation of 18-hydroxycorticosterone secretion in man. Sowers JR; Stern N J Clin Endocrinol Metab; 1982 Dec; 55(6):1046-51. PubMed ID: 7130335 [TBL] [Abstract][Full Text] [Related]
3. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man. Sowers JR; Beck FW Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674 [TBL] [Abstract][Full Text] [Related]
4. Effects of dietary sodium on circadian rhythm and physiological responses of 18-hydroxycorticosterone. Sowers JR; Martin VI; Beck FW Clin Sci (Lond); 1983 Mar; 64(3):295-301. PubMed ID: 6295691 [TBL] [Abstract][Full Text] [Related]
5. Dopaminergic modulation of corticosteroid responses to angiotensin II in man. Sowers JR; Beck FW Clin Exp Hypertens A; 1983; 5(5):651-64. PubMed ID: 6309435 [TBL] [Abstract][Full Text] [Related]
6. Role of dopamine in the regulation of aldosterone and 18-hydroxycorticosterone secretion in man. Sowers JR; Beck FW J Endocrinol Invest; 1984 Oct; 7(5):473-9. PubMed ID: 6096435 [TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid suppression enhances the 18-hydroxycorticosterone and aldosterone response to metoclopramide in man. Sowers JR; Beck FW; Stern N Life Sci; 1983 Dec; 33(25):2489-95. PubMed ID: 6645810 [TBL] [Abstract][Full Text] [Related]
8. Evidence for direct inhibitory effects of dopamine on zona glomerulosa secretion of 18-hydroxycorticosterone in rhesus monkeys. Sowers JR; Beck FW; Eggena P Life Sci; 1984 Jun; 34(24):2339-46. PubMed ID: 6727568 [TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatographic separation of corticosteroids in plasma of rats. Its application to the determination of the circadian rhythm of 18-hydroxycorticosterone related to aldosterone and corticosterone. Imaizumi N; Yamamoto I; Kamei M; Yoshida I; Miyauchi E; Kigoshi T; Hosojima H; Uchida K; Morimoto S Horm Res; 1987; 27(1):53-60. PubMed ID: 3623429 [TBL] [Abstract][Full Text] [Related]
11. Altered responses of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II and adrenocorticotropin in patients with a 18-hydroxycorticosterone-producing tumor. Uchida K; Kigoshi T; Iwasaki R; Morimoto S Jpn J Med; 1989; 28(4):446-51. PubMed ID: 2554039 [TBL] [Abstract][Full Text] [Related]
12. Dopaminergic control of circadian norepinephrine levels in patients with essential hypertension. Sowers JR J Clin Endocrinol Metab; 1981 Dec; 53(6):1133-7. PubMed ID: 7298797 [TBL] [Abstract][Full Text] [Related]
13. Dopaminergic control of 18-hydroxycorticosterone responses to posture, isometric exercise, and diuretic administration in normal man. Sowers JR; Martin VI; Stern N; Berg G J Clin Endocrinol Metab; 1982 Sep; 55(3):475-80. PubMed ID: 7096536 [TBL] [Abstract][Full Text] [Related]
14. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man. Sowers JR; Sharp B; McCallum RW J Clin Endocrinol Metab; 1982 Apr; 54(4):869-71. PubMed ID: 7037817 [TBL] [Abstract][Full Text] [Related]
15. [The effect of metoclopramide and dopamine on mineralocorticoid secretion--in vivo and in vitro studies]. Ojima M; Itoh N; Kusano Y; Yaginuma K; Fukuchi S Nihon Naibunpi Gakkai Zasshi; 1986 Mar; 62(3):197-207. PubMed ID: 3709883 [TBL] [Abstract][Full Text] [Related]
16. Effect of metoclopramide and domperidone on aldosterone, 18-hydroxycorticosterone and prolactin secretion in the rhesus monkey. Sowers JR; Eggena P; Phillips D Metabolism; 1982 Dec; 31(12):1219-23. PubMed ID: 7144566 [TBL] [Abstract][Full Text] [Related]
17. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production. Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240 [TBL] [Abstract][Full Text] [Related]
18. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism. Miyamori I; Yasuhara S; Matsubara T; Okamoto S; Ikeda M; Koshida H; Morise T; Takeda Y; Takeda R; Vecsei P Endocrinol Jpn; 1987 Dec; 34(6):809-19. PubMed ID: 2836182 [TBL] [Abstract][Full Text] [Related]
19. Increased 18-hydroxycorticosterone responses to frusemide in essential hypertension. Semple PF; Mason PA; Fraser R Clin Endocrinol (Oxf); 1980 May; 12(5):473-81. PubMed ID: 7428185 [TBL] [Abstract][Full Text] [Related]
20. Effect of bromocriptine on the control of plasma aldosterone diurnal variation in normal supine man. degli Uberti EC; Fabbri BL; Margutti AR; Fersini CM; Pansini R Horm Res; 1979; 10(2-3):64-78. PubMed ID: 220171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]